市場調査レポート

商品コード

1766575

集団検診市場：製品タイプ別、用途別、性別、年齢層別、提供形態別、エンドユーザー別、地域別

Population Screening Market, By Product Type, By Application Area, By Gender, By Age Group, By Delivery Mode, By End User,By Geography

出版日: 2025年06月09日
発行: Coherent Market Insights
ページ情報: 英文 140 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,500 675,225円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,050,350円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,500,500円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=150.05円

全表示
概要
目次

概要

サンプル依頼リストに入れる

集団検診市場は、2025年には261億米ドルと推定され、2032年には377億7,000万米ドルに達すると予測され、2025年から2032年までの年間平均成長率（CAGR）は5.42%で成長する見込みです。

レポート範囲		レポート詳細
基準年	2024	2025年の市場規模	261億米ドル
実績データ	2020年から2024年まで	予測期間	2025年から2032年
予測期間：2025年～2032年CAGR：	5.42%	2032年の価値予測	377億7,000万米ドル

世界の集団検診市場は、病気の早期発見と予防を目指す予防ヘルスケアの重要な側面として浮上してきました。集団検診は、特定の疾患を発症するリスクのある人々を特定し、タイムリーな介入と健康状態の改善を可能にするため、無症状の人々を体系的に検査します。世界が慢性疾患の負担増加とヘルスケアコストの増加に直面している中、効果的な集団検診プログラムの重要性はいくら強調してもしすぎることはないです。この市場には、遺伝子検診、がん検診、心血管検診、感染症検診など、さまざまな検診と検査が含まれます。人工知能とゲノミクスの統合などの技術の進歩により、集団検診市場は今後数年間で大きな成長と革新を遂げる態勢が整っています。

市場力学：

世界の集団検診市場は、慢性疾患の有病率の上昇、疾患の早期発見に対する意識の高まり、予防ヘルスケアを推進する政府の取り組みなど、いくつかの要因によって牽引されています。がん、糖尿病、心血管障害などの疾病負担の増大により、リスクのある個人を特定し、タイムリーな介入を可能にする効果的な検診プログラムの必要性が高まっています。さらに、リキッドバイオプシー、次世代シーケンシング、AIを活用した画像解析などの検診技術の進歩は、検診と検査の精度と効率を高め、市場の成長をさらに促進すると期待されています。しかし市場には、検診と検査に関連する高額な費用、特定の地域におけるヘルスケアサービスへのアクセスの制限、偽陽性結果や過剰診断に関する懸念など、一定の抑制要因も存在します。さらに、遺伝子検診やデータプライバシーをめぐる規制上の課題や倫理的配慮が、市場成長の障害となる可能性もあります。こうした課題にもかかわらず、集団検診市場は利害関係者に大きな機会を提供しています。遠隔医療と遠隔モニタリング・ソリューションの採用が増加しているため、特に十分なサービスを受けていない地域における検診プログラムの範囲が拡大する可能性があります。さらに、集団検診と薬理ゲノミクスやリスク層別化のような個別化医療アプローチとの統合は、的を絞った介入を可能にし、患者の転帰を最適化することができます。世界中のヘルスケアシステムが予防医療と費用対効果に重点を置いているため、集団検診市場は今後数年間で大幅な成長と革新が見込まれます。

本調査の主な特徴

本レポートは、世界の集団検診市場を詳細に分析し、2024年を基準年とした予測期間（2025-2032年）の市場規模（10億米ドル）と複合年間成長率（CAGR%）を提供しています。
さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて解説しています。
また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競合戦略などに関する重要な考察も提供しています。
企業ハイライト、製品ポートフォリオ、主要なハイライト、業績、戦略などのパラメータに基づいて、世界の集団検診市場の主要企業プロファイルを掲載しています。
このレポートからの洞察は、マーケティング担当者や企業の経営陣が、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にします。
世界の集団検診市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
利害関係者は、世界の集団検診市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 26.10 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.42%	2032 Value Projection:	USD 37.77 Bn

The global population screening market has emerged as a crucial aspect of preventive healthcare, aiming to detect and prevent diseases at an early stage. Population screening involves the systematic testing of asymptomatic individuals to identify those at risk of developing specific conditions, enabling timely intervention and improved health outcomes. As the world faces an increasing burden of chronic diseases and rising healthcare costs, the importance of effective population screening programs cannot be overstated. This market encompasses various screening tests, including genetic screening, cancer screening, cardiovascular screening, and infectious disease screening, among others. With advancements in technology, such as the integration of artificial intelligence and genomics, the population screening market is poised for significant growth and innovation in the coming years.

Market Dynamics:

The global population screening market is driven by several factors, including the rising prevalence of chronic diseases, increasing awareness about early disease detection, and government initiatives to promote preventive healthcare. The growing burden of diseases such as cancer, diabetes, and cardiovascular disorders has heightened the need for effective screening programs to identify at-risk individuals and enable timely intervention. Moreover, advancements in screening technologies, such as liquid biopsy, next-generation sequencing, and AI-powered imaging analysis, are expected to enhance the accuracy and efficiency of screening tests, further driving market growth. However, the market also faces certain restraints, such as high costs associated with screening tests, limited access to healthcare services in certain regions, and concerns regarding false-positive results and overdiagnosis. Additionally, regulatory challenges and ethical considerations surrounding genetic screening and data privacy may pose obstacles to market growth. Despite these challenges, the population screening market presents significant opportunities for stakeholders. The increasing adoption of telehealth and remote monitoring solutions has the potential to expand the reach of screening programs, particularly in underserved areas. Furthermore, the integration of population screening with personalized medicine approaches, such as pharmacogenomics and risk stratification, can enable targeted interventions and optimize patient outcomes. As healthcare systems worldwide focus on preventive care and cost-effectiveness, the population screening market is expected to witness substantial growth and innovation in the coming years.

Key Features of the Study:

This report provides in-depth analysis of the global population screening market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global population screening market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Thermo Fisher Scientific, Bio-Rad Laboratories, QIAGEN, Hologic, PerkinElmer, Illumina, Cepheid, Genomic Health, Agilent Technologies, Ortho Clinical Diagnostics, Becton, Dickinson and Company, and Beckman Coulter.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global population screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global population screening market.

Market Segmentation

Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Hardware Equipment
- Diagnostic Devices
- Sample Collection Devices
- Imaging Equipment
- Testing or Laboratory Services
- Laboratory Testing Kits
- Point-of-Care Testing
- Blood and Urine Testing Services
- Analytics or Interpretation
- Software Solutions for Data Analysis
- Interpretation Services
- Reporting Tools
- Others
Application Area Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology
- Cardiology
- Immunology
- Neurology
- Genetics and Genomics
- Endocrinology and Metabolism
- Infectious Diseases
- Reproductive and Maternal Health
- Pediatrics and Neonatology
- Psychiatry and Mental Health
- Hematology
- Gastroenterology
- Nephrology
Gender Insights (Revenue, USD Bn, 2020 - 2032)
- Male
- Female
Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Pediatric Population
- Adult Population
- Elderly Population
Delivery Mode Insights (Revenue, USD Bn, 2020 - 2032)
- Onsite/Facility-Based Screening
- Remote/Telehealth Screening
- Mobile Screening Units
- Self-Testing/Home-Based
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Diagnostic Laboratories
- Academic & Research Institutes
- Government and Public Health Agencies
- Specialty Clinics
- Others
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Roche Diagnostics
- Abbott Laboratories
- Siemens Healthineers
- Thermo Fisher Scientific
- Bio-Rad Laboratories
- QIAGEN
- Hologic
- PerkinElmer
- Illumina
- Cepheid
- Genomic Health
- Agilent Technologies
- Ortho Clinical Diagnostics
- Becton, Dickinson and Company
- Beckman Coulter

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Population Screening Market, By Product Type
- Global Population Screening Market, By Application Area
- Global Population Screening Market, By Gender
- Global Population Screening Market, By Age Group
- Global Population Screening Market, By Delivery Mode
- Global Population Screening Market, By End User
- Global Population Screening Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Population Screening Market, By Product Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hardware Equipment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Diagnostic Devices
  - Sample Collection Devices
  - Imaging Equipment
Testing or Laboratory Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Laboratory Testing Kits
  - Point-of-Care Testing
  - Blood and Urine Testing Services
Analytics or Interpretation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Software Solutions for Data Analysis
  - Interpretation Services
  - Reporting Tools
  - Others

5. Global Population Screening Market, By Application Area, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Immunology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Genetics and Genomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Endocrinology and Metabolism
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Reproductive and Maternal Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pediatrics and Neonatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Psychiatry and Mental Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hematology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Gastroenterology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Nephrology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Population Screening Market, By Gender, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Population Screening Market, By Age Group, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pediatric Population
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Adult Population
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Elderly Population
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Population Screening Market, By Delivery Mode, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Onsite/Facility-Based Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Remote/Telehealth Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Mobile Screening Units
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Self-Testing/Home-Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Population Screening Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Academic & Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Government and Public Health Agencies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Population Screening Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

11. Competitive Landscape

Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
QIAGEN
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hologic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
PerkinElmer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Illumina
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cepheid
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Genomic Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Agilent Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ortho Clinical Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Beckman Coulter
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

12. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

13. References and Research Methodology

References
Research Methodology
About us

集団検診市場：製品タイプ別、用途別、性別、年齢層別、提供形態別、エンドユーザー別、地域別

Population Screening Market, By Product Type, By Application Area, By Gender, By Age Group, By Delivery Mode, By End User,By Geography

市場力学：

本調査の主な特徴

目次

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界の集団検診市場、製品タイプ別、2020年～2032年

第5章世界の集団検診市場、用途別、2020年～2032年

第6章世界の集団検診市場、性別、2020年～2032年

第7章世界の集団検診市場、年齢層別、2020年～2032年

第8章世界の集団検診市場、提供形態別、2020年～2032年

第9章世界の集団検診市場、エンドユーザー別、2020年～2032年

第10章世界の集団検診市場、地域別、2020年～2032年

第11章競合情勢

第12章アナリストの推奨事項

第13章参考文献と調査手法

Market Dynamics:

Key Features of the Study:

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Population Screening Market, By Product Type, 2020-2032, (USD Bn)

5. Global Population Screening Market, By Application Area, 2020-2032, (USD Bn)

6. Global Population Screening Market, By Gender, 2020-2032, (USD Bn)

7. Global Population Screening Market, By Age Group, 2020-2032, (USD Bn)

8. Global Population Screening Market, By Delivery Mode, 2020-2032, (USD Bn)

9. Global Population Screening Market, By End User, 2020-2032, (USD Bn)

10. Global Population Screening Market, By Region, 2020 - 2032, Value (USD Bn)

11. Competitive Landscape

12. Analyst Recommendations

13. References and Research Methodology

集団検診市場：製品タイプ別、用途別、性別、年齢層別、提供形態別、エンドユーザー別、地域別

Population Screening Market, By Product Type, By Application Area, By Gender, By Age Group, By Delivery Mode, By End User,By Geography

市場力学：

本調査の主な特徴

目次

第1章 調査の目的と前提条件

第2章 市場の展望

第3章 市場力学、規制、動向分析

第4章 世界の集団検診市場、製品タイプ別、2020年～2032年

第5章 世界の集団検診市場、用途別、2020年～2032年

第6章 世界の集団検診市場、性別、2020年～2032年

第7章 世界の集団検診市場、年齢層別、2020年～2032年

第8章 世界の集団検診市場、提供形態別、2020年～2032年

第9章 世界の集団検診市場、エンドユーザー別、2020年～2032年

第10章 世界の集団検診市場、地域別、2020年～2032年

第11章 競合情勢

第12章 アナリストの推奨事項

第13章 参考文献と調査手法

Market Dynamics:

Key Features of the Study:

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Population Screening Market, By Product Type, 2020-2032, (USD Bn)

5. Global Population Screening Market, By Application Area, 2020-2032, (USD Bn)

6. Global Population Screening Market, By Gender, 2020-2032, (USD Bn)

7. Global Population Screening Market, By Age Group, 2020-2032, (USD Bn)

8. Global Population Screening Market, By Delivery Mode, 2020-2032, (USD Bn)

9. Global Population Screening Market, By End User, 2020-2032, (USD Bn)

10. Global Population Screening Market, By Region, 2020 - 2032, Value (USD Bn)

11. Competitive Landscape

12. Analyst Recommendations

13. References and Research Methodology

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界の集団検診市場、製品タイプ別、2020年～2032年

第5章世界の集団検診市場、用途別、2020年～2032年

第6章世界の集団検診市場、性別、2020年～2032年

第7章世界の集団検診市場、年齢層別、2020年～2032年

第8章世界の集団検診市場、提供形態別、2020年～2032年

第9章世界の集団検診市場、エンドユーザー別、2020年～2032年

第10章世界の集団検診市場、地域別、2020年～2032年

第11章競合情勢

第12章アナリストの推奨事項

第13章参考文献と調査手法